RE: Listening Session: Optimizing the Food and Drug Administration's Use of and Processes for Advisory Committees; Public Meeting; Request for Comments. [Docket No. FDA-2024-N-1809]
RE: Listening Session: Optimizing the Food and Drug Administration's Use of and Processes for Advisory Committees; Public Meeting; Request for Comments. [Docket No. FDA-2024-N-1809]
Date Issued
Endorsement